NEWSROOM
-
Title
-
- A new breakthrough of immunotherapy for luminal-type breast cancer
- Voice of China at ESSO | FUSCC was invited to the international stage, showcasing the wisdom and elegance of Chinese colorectal oncologists
- Non-invasive test developed for urological cancer
- Doctor's pioneering research can light up hidden cancers
- Local medics develop precise treatment for deadliest breast cancer
- Shanghai medical experts make cancer treatment discovery
- FUSCC signed a sister institution agreement with N.N. Blokhin NMRCO
- Fudan University Shanghai Cancer Center CUP001 was Presented at ESMO 2023 Professor Luo Zhiguo: The World's First Phase III Clinical Study in Patients with Cancer of Unknown Primary Met its Primary Endpoint
- Precise medicine, digital tech boost breast cancer treatment
- The 11th FUSCC-CRIKU Joint Symposium on Tumor Biology was convened at Kanazawa